The Live Long Podcast

May 13, 2019

Building tools to engineer the human body

About this episode

Innovation in human biology is evolving at breakneck speed. Artificial intelligence, data science and pharmaceutical discoveries – combined with a deeper understanding of how the body works at a cellular level – are creating exciting opportunities to extend health span.   Dr. Ron Alfa is Senior Vice President of Discovery & Product at Recursion, a clinical-stage biotechnology company, recently named by Fast Company as one the World’s Most Innovative Companies for 2019. In this LLAMA podcast interview, with Peter Bowes, Dr, Alfa explains Recursion’s mission to create a map of human cellular biology and find novel treatment for the diseases of aging.

Connect with Dr. Alfa: Bio | Recursion

This conversation was recorded at TEDMED

In the episode we cover:

  • How Recursion is using machine learning and computational biology to change the way drugs are getting to patients from the laboratory.
  • Building tools to better understand the safety and efficacy of new molecules for use in the clinic.
  • How drug discovery works and why it is such a long scientific process.

DISCOUNTS & AFFILIATION DISCLOSURES

This podcast is supported by affiliate arrangements with a select number of companies. We have arranged discounts on certain products and receive a small commission on sales. The income helps to cover production costs and ensures that our interviews, sharing information about human longevity, remain free for all to listen. See our SHOP for more details.

Audio-only platforms

The Live Long podcast, a HealthSpan Media LLC production, shares ideas but does not offer medical advice. If you have health concerns of any kind, or you are considering adopting a new diet or exercise regime, you should consult your doctor.

Get the latest episode in your inbox